<DOC>
	<DOCNO>NCT00389220</DOCNO>
	<brief_summary>The purpose study compare BioMatrix Flex ( Biolimus A9-Eluting ) stent system Cypher SELECT ( Sirolimus-Eluting ) stent system non-inferiority trial .</brief_summary>
	<brief_title>Limus Eluted From A Durable Versus ERodable Stent Coating</brief_title>
	<detailed_description>Compare safety efficacy BioMatrix Flex ( Biolimus A9-Eluting ) stent system Cypher SELECT ( Sirolimus-Eluting ) stent system prospective , multi-center , randomize , control , non-inferiority trial patient undergo percutaneous coronary intervention routine clinical practice .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>Age &gt; = 18 year ; Symptomatic coronary artery disease include patient chronic stable angina , silent ischemia , acute coronary syndrome include nonST elevation myocardial infarction STelevation myocardial infarction ; Presence one coronary artery stenoses &gt; 50 % native coronary artery saphenous bypass graft 2.25 3.5 mm diameter cover one multiple stent ; No limitation number treat lesion , vessel , lesion length Pregnancy ; Known intolerance aspirin , clopidogrel , heparin , stainless steel , Sirolimus , Biolimus contrast material ; Inability provide informed consent ; Currently participate another trial reach first endpoint ; Planned surgery within 6 month PCI unless dual antiplatelet therapy maintain throughout perisurgical period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Coronary Disease</keyword>
	<keyword>Coronary Stenosis</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Coronary Restenosis</keyword>
	<keyword>Drug Eluting Stent</keyword>
</DOC>